Navigation Links
First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama
Date:11/21/2008

HOUSTON, Nov. 21 /PRNewswire-USNewswire/ -- The University of Texas M. D. Anderson Cancer Center marked the beginning of a collaborative effort to eradicate breast cancer in Panama through the Partnership for Breast Cancer Awareness and Research of the Americas today at an event with Laura Bush, the First Lady of the United States, and Vivian Fernandez de Torrijos, the First Lady of Panama.

Joining M. D. Anderson in the initiative are the U.S. Department of State and Susan G. Komen for the Cure(r) who are working closely with the First Lady of Panama to finalize the partnership, which currently brings together leading medical experts and breast cancer awareness advocates in the United States, Mexico, Brazil and Costa Rica.

Breast cancer is the second leading cause of cancer-related deaths among women in Panama. According to the Panamanian Ministry of Health, more than 25 percent of Panama's population of 3.3 million is comprised of women over 40 years old and is at a greater risk of developing the disease since risk increases with age.

First announced by Mrs. Laura Bush in July 2007, the Partnership for Breast Cancer Awareness and Research of the Americas is designed to increase early breast cancer detection and reduce related deaths in the region through improved awareness, clinical resources and world-class research. The Partnership is facilitated by the U.S. Department of State and is initiated and implemented locally by participating countries. M. D. Anderson serves as the Partnership's lead medical adviser.

In Panama, the Partnership will offer the opportunity to advance new and existing initiatives focused on reducing the burden of breast cancer. Collaborative efforts in the areas of research, capacity-building and women's empowerment will be promoted.

Representatives from M. D. Anderson, Susan G. Komen For the Cure(r) and the U.S. State Department joined Mrs. Laura Bush and Mrs. Vivian Fernandez de Torrijos to announce the initiative at an event held at the Ministry of Foreign Affairs in Panama City.

"Breast cancer continues to have a tremendous impact on women in Panama, despite good efforts to raise awareness of early detection and prevention," said Ana Maria Gonzalez-Angulo, M.D., assistant professor in M. D. Anderson's Department of Breast Medical Oncology, who represented M. D. Anderson at the announcement in Panama City. "By working collectively to advance awareness, research, training and community outreach, we can change attitudes and behaviors about breast cancer which will in turn save lives."

A team of 33 M. D. Anderson scientists and physicians serve on an advisory board for the Partnership for Breast Cancer Awareness and Research of the Americas and oversee the contribution of medical and public education resources to the initiative. M. D. Anderson has committed to making available its extensive library of educational materials on a broad spectrum of topics related to breast cancer, much of which is available in Spanish. In addition, M. D. Anderson will explore opportunities to develop specific satellite educational programs on breast cancer topics for the medical community and offer its faculty and staff as a resource to medical personnel in Panama.

John Mendelsohn, M.D., president of M. D. Anderson said, "We are pleased to have the opportunity to extend our work with the Partnership to Panama. Mrs. Fernandez de Torrijos is commended for her dedication and commitment to reducing breast cancer and her efforts to engage the Partnership for the benefit of women in Panama, across Latin America and around the world."

To date, M. D. Anderson has established academic and educational relationships with 25 premier cancer centers around the world, and partnered with the Department of State on a similar breast cancer initiative in the Middle East formed in 2006.

About M. D. Anderson

The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 39 Comprehensive Cancer Centers designated by the National Cancer Institute. For five of the past eight years, M. D. Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News and World Report.

This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com.


'/>"/>
SOURCE The University of Texas M. D. Anderson Cancer Center
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery ... now accredited by The Joint Commission for chemical dependency and behavioral health services. ... U.S. health care organizations that meet the commission’s rigorous standards. Accreditation by The ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... Clinical Plus Coating System for clients that rely on safety and cleanliness. This ... of microorganisms. , Silver has been used for centuries for its antimicrobial properties. ...
(Date:9/20/2017)... ... 2017 , ... Renal Support Network’s annual essay contest celebrates ... The theme “Describe a positive decision that you have made about your healthcare” ... one qualification— to have been diagnosed with chronic kidney disease. This year the ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... medical device compliance and commercialization, has just released a new white paper ... is more adamant than ever about medical device, pharmaceutical, and combination product ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
(Date:9/5/2017)... Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ORMP) ... the development of oral drug delivery systems, announced today ... U.S. Food and Drug Administration (FDA) regarding ORMD-0801, the ... At the meeting, the FDA gave clear ... would be a Biologics License Application (BLA).  Such a ...
(Date:8/31/2017)... -- PM360,s annual Innovations Issue, published in December, ... happening across the industry. Established six years ago, this ... a comprehensive look at the newest and most exciting ... companies, startups, divisions, products, services, and strategies from the ... in this industry wants to do better—in all facets ...
Breaking Medicine Technology: